AntimetabolitesAntimetabolites, AntineoplasticAntineoplastic Combined Chemotherapy ProtocolsFloxuridineTetrahydrouridineTrabeculectomyChemotherapy, AdjuvantAntineoplastic AgentsInosine MonophosphateMethotrexatePhosphoribosyl PyrophosphateMitomycinFluorouracilCytarabine6-MercaptopurineLeukemia L1210Folic Acid AntagonistsDeoxycytidinePurinesCombined Modality TherapyCisplatinNeoplasmsDrug SynergismCyclophosphamideDoxorubicinDrug Screening Assays, AntitumorTreatment OutcomeCell SurvivalDrug Evaluation, PreclinicalNeoadjuvant TherapyTumor Cells, CulturedDisease-Free SurvivalEtoposideBreast NeoplasmsNeoplasm StagingSurvival AnalysisCell CyclePrognosisCell DivisionSurvival RateLung NeoplasmsDrug Administration ScheduleCarboplatinPaclitaxelInduction ChemotherapyVinblastineCell LineNeoplasm Recurrence, LocalTaxoidsIfosfamideDrug Resistance, NeoplasmBleomycinOrganoplatinum CompoundsKineticsAnthracyclinesAntineoplastic Agents, AlkylatingChemotherapy, Cancer, Regional PerfusionSalvage TherapyCarcinoma, Non-Small-Cell LungFollow-Up StudiesOvarian NeoplasmsNeoplasm MetastasisTesticular NeoplasmsVomitingNeutropeniaTransplantation, AutologousAdenocarcinomaNauseaLymphoma, Non-HodgkinAntineoplastic Agents, PhytogenicRadiotherapy, AdjuvantHodgkin DiseaseTime FactorsColorectal NeoplasmsRadiotherapyAntibiotics, AntineoplasticDacarbazineClinical Trials as TopicProspective StudiesNeoplasms, Germ Cell and EmbryonalCarmustineLomustineGranulocyte Colony-Stimulating FactorCamptothecinKaplan-Meier EstimatePlatinum CompoundsBrain NeoplasmsBone Neoplasms